Course of hypochondriasis in an international primary care study
Author
dc.contributor.author
Simon, Gregory E.
Author
dc.contributor.author
Gureje, Oye
Author
dc.contributor.author
Fullerton, Claudio
Admission date
dc.date.accessioned
2019-01-29T15:32:22Z
Available date
dc.date.available
2019-01-29T15:32:22Z
Publication date
dc.date.issued
2001
Cita de ítem
dc.identifier.citation
General Hospital Psychiatry, Volumen 23, Issue 2, 2018, Pages 51-55
Identifier
dc.identifier.issn
01638343
Identifier
dc.identifier.other
10.1016/S0163-8343(01)00115-3
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161632
Abstract
dc.description.abstract
Hypochondriasis is frequently defined as a chronic condition distinct from anxiety and depressive disorders. Consecutive primary care attenders (n=25, 916) were screened using the General Health Questionnaire and a stratified random sample (n=5447) completed a baseline diagnostic assessment. All patients with significant psychiatric symptoms and a random sample of remaining patients (n=3201) were asked to complete a follow-up diagnostic assessment 12 months later. Of patients meeting an abridged definition of hypochondriasis at baseline, 18% continued to do so at follow-up and an additional 16% continued to report hypochondriacal worries. 45% of those with hypochondriasis at follow-up also met criteria for DSM-IV anxiety or depressive disorder. Follow-up anxiety or depressive disorder was significantly associated with both onset and persistence of hypochondriasis. Hypochondriasis is moderately stable over time. The clear distinction between hypochondriasis and anxiety/depressive disord